2-(4-([4-(propan-2-yl)phenyl]methyl)piperazin-1-yl)ethan-1-ol

Catalog No. :
ACMXGC459
CAS No. :
415714-03-3
Molecular Formula :
C16H26N2O
Molecular Weight :
262.40

IUPAC Name:2-(4-(4-isopropylbenzyl)piperazin-1-yl)ethan-1-ol

2-(4-([4-(propan-2-yl)phenyl]methyl)piperazin-1-yl)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$193.00Login to see priceInquiryInquiry
5g98%$582.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-([4-(propan-2-yl)phenyl]methyl)piperazin-1-yl)ethan-1-ol
IUPAC Name2-(4-(4-isopropylbenzyl)piperazin-1-yl)ethan-1-ol
MDL No.MFCD01307053
Molecular FormulaC16H26N2O
Molecular Weight262.40
SMILESOCCN1CCN(CC2=CC=C(C(C)C)C=C2)CC1
InChI KeyGNYZZGGDDFSNFI-UHFFFAOYSA-N
Synonym2-(4-([4-(Propan-2-yl)phenyl]methyl)piperazin-1-yl)ethan-1-ol;1-Piperazineethanol, 4-[[4-(1-methylethyl)phenyl]methyl]-;2-(4-(4-Isopropylbenzyl)piperazin-1-yl)ethan-1-ol
CAS No.415714-03-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMXGC459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXGCW926 route compound structure diagram
    ACXGCW926122-03-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXGC459 route product structure diagram
    ACMXGC459415714-03-3
Inquiry

2. ACMXGC459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKJYT926 route compound structure diagram
    ACKJYT92673789-86-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXGC459 route product structure diagram
    ACMXGC459415714-03-3
Inquiry

Comments (0)